Prostate cancer can often be successfully treated if it is diagnosed at an early stage. Once the disease has formed daughter tumors in the bones, however, it becomes life-threatening. The standard treatment at this advanced stage is chemotherapy. Doctors also employ radiation and hormonal treatments. However, many active ingredients become ineffective because most carcinomas develop resistance with time.
Faster to the site of action
Scientists at Bayer HealthCare are now testing a new drug product that is designed to target bone metastasis: Alpharadin, an alpha radiation substance, can be easily administered intravenously and finds its way into the skeleton within 10 minutes. This means that other organs and tissues are only exposed to the radiation for a short time.